Home Page
Media Coverage
Proneuron Biotechnologies: Treatment for Spinal Cord Injury and other Neurological Disorders
Home Page
   Company
 
      Technology
 
       Therapies
 
       Clinical Studies
 
      News & Events
 
     Links
 
   Careers
 
True healers of disease
July, 12 2001
By Helen Schary Motro
The Internet Jerusalem Post.

The Internet Jerusalem Post website: http://www.jpost.com

Millions across America last week watched a medical miracle broadcast on the NBC nightly news: a 19-year-old paraplegic Colorado woman using her own legs to move again. After a car accident last year paralyzed her from the waist down, Melissa Holley underwent experimental surgery. She has begun to regain feeling in her feet and legs, and slowly but surely is overcoming the prognosis of a lifetime in a wheelchair.

The nationwide television report went on to interview the doctor who heads the medical arm of the company which developed the ground-breaking surgical procedure. Dr. Valentin Fulga spoke not from the Mayo Clinic, the National Institutes of Health, Cedars Sinai in Los Angeles, or Mass General in Boston. Fulga's company, Proneuron Biotechnologies, operates out of the industrial park in Ness Ziona.

Developed by Michal Schwartz, professor of neuroimmunology at the Weizmann Institute of Science, the treatment involves harvesting the patient's white blood cells, processing them, and injecting these macrophages into the spinal sac to regenerate severed nerve connectors.

Professor Schwartz's ideas led to experimental surgery approved for trials by the US Food and Drug Administration.

Last July, Holley flew to Israel to become the first person to undergo the treatment, which was performed at Sheba Hospital in Tel Hashomer. Neurosurgeon Nahshon Koneller, who has performed three such operations, said, "We are talking about regeneration of the spinal cord, which has never been recorded in the past."

The tragedy of spinal-cord injuries gained worldwide attention after actor Christopher Reeve, best known for his "Superman" role, was paralyzed in a riding accident. Reeve has made his injury a springboard for publicizing the need for research in an area of medicine which which deals with 8,000 new cases annually in the US.

Besides the millions who saw the July 5 NBC broadcast, anyone could see it replayed on MSNBC's Web site, which also reprinted a Reuters news report of Holley's positive response and provided a link to the Proneuron Web site.

Proneuron's detailed Web site opens to a nearly blank page with a single quote from Hippocrates: "Natural forces within ourselves are the true healers of disease." The company states that its aim is to use "the modulation of natural mechanisms within the body to address currently incurable disorders." The site gives a description of the technique and references to Schwartz's scientific publications, and calls for volunteers to participate in the clinical trial.

The most salient criterion is that treatment must be initiated within seven days of injury. Thus dissemination of Proneuron's existence is crucial. In Holley's case it was her father who stumbled across it while searching the Internet immediately following the accident. But through media exposure, the word has slowly begun to spread.

In February, CBS TV's Early Show interviewed Holley and Fulga. And so in June, a Colorado youth paralyzed in a snowboarding accident was flown to Israel to become the fourth person to undergo Proneuron's surgery. His father said of Proneuron: "It's the only game in town right now." While Proneuron is now in the limelight, other Israelis strive for breakthroughs in technology, science and medicine.

Israel is in the world's headlines daily, with killings, kidnappings, snipers, hit teams, and suicide bombers. In the world's consciousness, the word "Israel" has become equated with conflict and fear.

Last week The Los Angeles Times ran a front-page story titled "War eats at soul of Israel"; The Orlando Sentinel headlined "...Tensions simmer..." and The New York Times published "Little 'quiet' in Israel..." and "Israel affirms policy of assassinating militants." The current New Yorker magazine features a report about Palestinian groups returning to the irredentist slogan of a Palestine reaching "from river to sea."

But the size of the headlines has been shrinking. Death in the Middle East is becoming old hat. Art? Culture? Literature? Israelis don't make those pages. Sports is linked to terrorism - for example, this headline in the Milwaukee Journal Sentinel: "Fearing violence, thousands refuse to participate in Jewish Olympics in Israel." Tourism and pilgrimages are under its shadow as well - recently in The Denver Post: "Local families reconsider trips to Mideast amid violence."

Proneuron's greatest benefit is to offer hope to those without hope. But a side effect is that it reminds the world that Israel and Israelis are involved not only in hurting and being hurt, but in using their minds and talents to help. And that some even remember Hippocrates.


Disclaimer | Site Map | Home Page| Contact Us

Proneuron Biotechnologies is engaged in research
related to spinal cord injuries and paralysis cure.

Top of page Print this page


















Our friends on the web
Judaica Shop
Spinal Cord Injury
Virtual Keyboard
Spinal Cord Injuries
Flowers Israel
Mobile NoteTaker
Marine Construction
Systems On Module
Rugged Computers
Mobile Phone Disabler
Digital Pen